| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5M | — | +3.5% |
| R&D Expense | $11.3M | — | +18.1% |
| SG&A Expense | $8.1M | — | +25.8% |
| Operating Income | -$17.8M | — | -23.0% |
| Interest Expense | $1.3M | — | +8.3% |
| Net Income | -$19.2M | — | -24.9% |
| EPS (Basic) | -$0.06 | — | -20.0% |
| EPS (Diluted) | -$0.06 | — | -20.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $31.9M | — | -15.6% |
| Current Assets | $38.6M | +58.4% | -12.3% |
| Total Assets | $56.9M | +30.8% | -11.7% |
| Current Liabilities | $20.7M | -10.1% | +22.6% |
| Long-term Debt | $24.2M | -12.2% | -12.6% |
| Total Liabilities | $51.1M | -8.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$21.8M | — | -12.6% |
| Capital Expenditures | $6K | — | -62.5% |
| Investing Cash Flow | -$6K | — | +94.1% |
| Financing Cash Flow | $35.0M | — | +2910.0% |
| Free Cash Flow | -$21.8M | — | -12.5% |
| +5.3% |
| Stockholders' Equity | $5.8M | +147.7% | -63.5% |